The trials tell us that, under research conditions, GLP-1s can help people lose roughly 10 to 20 percent of body weight, improve blood sugar, blood pressure, and some lipid markers, and maintain benefits while the drug is continued
People often ask if children need to be on this for the rest of their lives
The signals start with changes in gastric distention, leading to decreased acyl-ghrelin, increased deacyl-ghrelin, and increased gastric leptin.47 As food enters the duodenum, other enzymes or hormones including enterokinase, cholecystokinin (CCK), glucose-dependent insulinotropic peptide (GIP, previously called gastric inhibitory polypeptide) and glucagon are all secreted and act systemically to promote postprandial satiety (Figure 2C).48 With food entry into the small intestine, intestinal L-cells release glucagon-like peptide 1 (GLP-1), which has wide ranging systemic effects promoting satiety.4951 Once food reaches the terminal ileum, enterocytes release peptide YY (PYY), oxyntomodulin and insulin-like peptide 5 (INSL5), which constitute the ileal brake and further delay gastric emptying and enteric motility.52 The cumulative effect is a central sensation of postprandial satiety, (Figure 2C)
For the best results, consume at least 3 liters of water each day
Liraglutide improves blood pressure and lipid profiles but increased heart rate by an average of 2 beats per minute in the SCALE-diabetes study [41]
resbiotic markets resM with a bold claim: a 300% increase in GLP-1 hormone production
